Research | OneLook Acronym Finder |
Serial Number | 86937435 |
Registration Number | 5076962 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Mark A. Paskar |
Attorney Docket Number | 0234449 |
Law Office Assigned | M30 |
Employee Name | OLANDRIA, WARREN L |
1971-01-20 | Date of First Use |
2016-03-11 | Application Filed |
2016-08-23 | Published for Opposition |
2016-11-08 | Location: PUBLICATION AND ISSUE SECTION |
2016-11-08 | Status: Live/Registered |
2016-11-08 | Trademark Registered |
2018-07-08 | Transaction Date |
Owner: | Akorn, Inc. |
Address | 1925 West Field Court Lake Forest LA 60045 |
Legal Entity Type | Corporation |
Legal Entity State | LA |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical products and preparations, namely, inhalants, injectables, nasal sprays and mists, oral liquids, oral solids and topicals for sterile aqueous ophthalmic solutions; ocular anesthetics; ophthalmic solutions for the treatment of elevated intraocular pressure in individuals with ocular hypertension or open-angle glaucoma; sterile indocyanine green for use as a cardiac diagnostic aid, a hepatic diagnostic aid and as a retinal diagnostic aid; hypnotic sedative anesthetic compounds; mydriatics; pharmaceutical preparations for the treatment of respiratory conditions; oral analgesics; oral analgesics in solution or liquid form; analgesic preparations; spinal anesthetics; anti-diarrheal agents; schedule III prescription synthetic narcotics; anxiolytics; anti-seizure medications; topical anesthetics; pharmaceutical preparations for treatment of arsenic, gold and mercury poisoning and acute lead poisoning; pharmaceutical preparations for treatment of opioid dependence; antibacterials, namely, antibacterial cleaners, antibacterial hand lotions, and antibacterial pharmaceuticals; pharmaceutical agents for treatment of respiratory ailments, prevention of endometrial hyperplasia and secondary amenorrhea; corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and musculoskeletal conditions; antiviral agents; anti-infectives; vitamins; dietary and nutritional supplements; magnesium supplements; antacids; pharmaceutical preparations for relief of nasal congestion, sinus pressure and sinus headache, nasal sprays; topicals for the treatment of arthritis, joint pain, back pain, foot pain and muscle pain; preparations for the relief of pain; pain relief medication; arthritis and joint pain preparations; cough suppressants and expectorants; cough drops and syrups; preparations for relief of symptoms of common colds and influenza; tablets, swabs, nasal sprays and effervescent preparations for treating colds and flu; tablets, swabs, nasal sprays and effervescent preparations for preventing colds and flu; medicated foot creams, lotions and ointments; medicated skin creams and lotions, including anti-itch creams; medicated tinctures and ointments for lip and skin care; eye drops; lubricant eye drops; eyelid cleanser, skin care around the eyelid; eye nutrition; contact lens comfort drops, veterinary pharmaceuticals; veterinary pharmaceuticals and preparations, namely, xylazine, ketamine, and reversing agents and antagonists for use in horses; veterinary pain relief medications, anesthetics and sedatives; veterinary ophthalmics; veterinary eye wash; veterinary eye lubricants and eye drops |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2016-03-15 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-03-16 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2016-06-22 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2016-06-28 | 4 CNRT R:Renewal |
NON-FINAL ACTION WRITTEN | 2016-06-28 | 5 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2016-06-28 | 6 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-06-28 | 7 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-06-30 | 8 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2016-07-07 | 9 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-07-14 | 10 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-07-14 | 11 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-07-14 | 12 CNSA O:Outgoing Correspondence |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-07-21 | 13 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-08-03 | 14 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2016-08-23 | 15 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-08-23 | 16 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2016-11-08 | 17 R.PR A:Allowance for Publication |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-10-21 | 18 ASCK I:Incoming Correspondence |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2020-11-18 | 19 ASGN I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-12-02 | 20 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2021-02-10 | 21 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2021-03-31 | 22 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2021-05-19 | 23 ASCK I:Incoming Correspondence |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2021-09-01 | 24 ASGN I:Incoming Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-09-16 | 25 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-09-16 | 26 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-09-16 | 27 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-09-16 | 28 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-09-16 | 29 CHAN I:Incoming Correspondence |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2021-11-08 | 30 REM1 E:E-Mail |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2021-11-10 | 31 ASCK I:Incoming Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-02-22 | 32 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-02-22 | 33 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-02-22 | 34 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-02-22 | 35 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-02-22 | 36 CHAN I:Incoming Correspondence |
TEAS SECTION 8 RECEIVED | 2023-05-08 | 37 ES8R I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2023-07-12 | 38 ASCK I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-09-21 | 39 APRE A:Allowance for Publication |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-10-27 | 40 APRE A:Allowance for Publication |
POST REGISTRATION ACTION MAILED - SEC. 8 | 2023-12-12 | 41 PRA8 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.